The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
127556621 12755662 1 I 20160908 20160916 20160916 EXP IT-JNJFOC-20160908963 JANSSEN CALZA L, MAGISTRELLI E, COLANGELI V, BORDERI M, CONTI M, MANCINI R, ET AL. IMPROVEMENT IN RENAL FUNCTION AND BONE MINERAL DENSITY AFTER A SWITCH FROM TENOFOVIR/EMTRICITABINE PLUS RITONAVIR-BOOSTED PROTEASE INHIBITOR TO RALTEGRAVIR PLUS NEVIRAPINE: A PILOT STUDY . ANTIVIR THER 2016;21 (3):217-224. 0.00 Y 0.00000 20160916 OT IT IT

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
127556621 12755662 1 PS DARUNAVIR DARUNAVIR 1 Oral Y N 21976 800 MG TABLETS QD
127556621 12755662 2 SS RITONAVIR. RITONAVIR 1 Oral Y 0 100 MG UNSPECIFIED QD
127556621 12755662 3 SS EMTRICITABINE W/TENOFOVIR EMTRICITABINETENOFOVIR DISOPROXIL 1 Unknown Y 0 UNKNOWN

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
127556621 12755662 1 HIV infection
127556621 12755662 2 HIV infection
127556621 12755662 3 HIV infection

Outcome of event

Event ID CASEID OUTC COD
127556621 12755662 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
127556621 12755662 Glycosuria
127556621 12755662 Hyperuricaemia
127556621 12755662 Hypokalaemia
127556621 12755662 Hypophosphataemia
127556621 12755662 Osteopenia
127556621 12755662 Osteoporosis
127556621 12755662 Proteinuria
127556621 12755662 Renal tubular dysfunction
127556621 12755662 Vitamin D deficiency

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found